Krystal Biotech (KRYS) PT Lowered to $216 at Chardan Capital Markets
Tweet Send to a Friend
Chardan Capital Markets analyst Geulah Livshits lowered the price target on Krystal Biotech (NASDAQ: KRYS) to $216.00 (from $219.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
